Gabriella Grimaldos
Overview
Explore the profile of Gabriella Grimaldos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
18
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seecheran N, Grimaldos K, McCallum P, Ramcharan P, Kawall J, Katwaroo A, et al.
Cardiol Ther
. 2025 Jan;
14(1):87-100.
PMID: 39826082
Introduction: This prospective, single-arm pharmacodynamic study assessed the effect of colchicine (COLC) [Strides Pharma UK Ltd, Watford, Hertfordshire, England] 0.5 mg administered orally once daily for 14 days on platelet...
2.
Seecheran N, Sukha D, Grimaldos K, Grimaldos G, Richard S, Ishmael A, et al.
Open Heart
. 2022 Sep;
9(2).
PMID: 36100318
Introduction: This prospective pharmacodynamic nutraceutical study assessed the effect of a 1-week trial of 30 g/day of 65% cocoa (dark chocolate) ( L.) consumption intervention on platelet reactivity. Methods: Patients...
3.
Seecheran N, Grimaldos K, Ali K, Grimaldos G, Richard S, Ishmael A, et al.
Cardiol Ther
. 2021 Oct;
10(2):561-568.
PMID: 34643895
Introduction: This prospective pharmacodynamic (PD) study assessed the effect of the sodium-glucose co-transporter-2 inhibitor (SGLT2i), dapagliflozin, on platelet reactivity. Methods: Patients with stable coronary artery disease (CAD) and type 2...
4.
Seecheran N, Ramdeen A, Debideen N, Ali K, Grimaldos K, Grimaldos G, et al.
Cardiol Ther
. 2020 Dec;
10(1):189-199.
PMID: 33306161
Introduction: This prospective pharmacodynamic (PD) study aimed to assess the effect of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin on platelet reactivity. Methods: Patients with stable coronary artery disease (CAD)...